Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hematological Toxicity”

12 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 12 of 12 results

Testing effectiveness (Phase 2)WithdrawnNCT06297629
What this trial is testing

A Phase I/II Trial to Assess the Efficacy and Toxicity of ASTX727 (Oral Decitabine/Cedazuridine) for the Treatment of Hematological Neoplasms After Allogeneic Stem Cell Transplantation

Who this might be right for
Allogeneic Stem Cell Transplantation
M.D. Anderson Cancer Center
Not applicableActive Not RecruitingNCT04167683
What this trial is testing

Muscle Dysfunction in Patients With Hematological Diseases Referred to Stem Cell Transplant

Who this might be right for
Hematologic DiseasesChronic Myeloid LeukemiaAcute Myeloid Leukemia+5 more
Rigshospitalet, Denmark 144
Testing effectiveness (Phase 2)Study completedNCT00841724
What this trial is testing

Study of a Reduced-toxicity "Submyeloablative" Conditioning Regimen Prior to Allogeneic Stem Cell Transplantation in Patients With Hematological Malignancies

Who this might be right for
Hematological Malignancies
Nantes University Hospital 82
Not applicableStudy completedNCT03828942
What this trial is testing

Monitoring the HeMAtological TOXicity of Drugs (HeMATOX)

Who this might be right for
Hematological AbnormalityHematotoxicity
Groupe Hospitalier Pitie-Salpetriere 1,000
Early research (Phase 1)WithdrawnNCT01336478
What this trial is testing

CD56+CD3- NK Cells Following Allogeneic Stem Cell Transplantation

Who this might be right for
Haematological MalignanciesAllogeneic Stem Cell TransplantCD56+CD3- NK Cells
Imperial College London
Testing effectiveness (Phase 2)Study completedNCT02215070
What this trial is testing

Pasireotide in Prevention of GI Toxicity

Who this might be right for
Hematological Malignancies
Anthony Sung, MD 37
Not applicableStudy completedNCT00177723
What this trial is testing

Towards Reducing Resistance and Hematological Toxicity of Linezolid

Who this might be right for
InfectionAdverse Effects
University of Pittsburgh 50
Not applicableStudy completedNCT00892502
What this trial is testing

Can Treatment With Bismuth Reduce Toxicity to Chemotherapy and Radiotherapy?

Who this might be right for
Hematological DiseasesHematological MalignanciesBlood Diseases+3 more
Copenhagen University Hospital at Herlev 50
Not applicableLooking for participantsNCT06503380
What this trial is testing

Real-world Study on the Management of Hematological Toxicities Associated With Targeted Therapies for Breast Cancer

Who this might be right for
Hematological ToxicityTargeted TherapyBreast Cancer
Fudan University 1,000
Not applicableStudy completedNCT05689450
What this trial is testing

Probability of Optimal Target Attainment of Amikacin in Patients With Febrile Neutropenia During Treatment for a Hematological Disorder

Who this might be right for
Febrile Neutropenia (FN)
University Hospital, Basel, Switzerland 92
Testing effectiveness (Phase 2)UnknownNCT00750126
What this trial is testing

Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Solid TumorsHematologic Neoplasms
University Hospital, Clermont-Ferrand 30
Large-scale testing (Phase 3)Not Yet RecruitingNCT07193420
What this trial is testing

Reduced Post-transplant Cyclophosphamide Dose in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplantation for Hematological Malignancies

Who this might be right for
GVHD - Graft-Versus-Host DiseaseHSCTHaploidentical Stem Cell Transplantation
Assistance Publique - Hôpitaux de Paris 180